Where does Isabelle de Cremoux work?

Isabelle de Cremoux is CEO and Managing Partner at Seventure Partners.

What check size does Isabelle de Cremoux write?

Isabelle de Cremoux typically writes checks of $685K – $27M.

What boards does Isabelle de Cremoux sit on?

Isabelle de Cremoux holds tracked board seats at Enterome Biosciences, Foodsmart, Maat Pharma, Polaris, Targedys, Vedanta.

Where did Isabelle de Cremoux go to school?

Isabelle de Cremoux studied at CentraleSupélec; DECF, ISEB.

Isabelle de Cremoux

Investor

CEO and Managing Partner at Seventure Partners

Paris, France

Writes $685K – $27M checks · typically $14M

Find your path to Isabelle

346 people in our graph can introduce you to Isabelle.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Xavier Collot to introduce you to Isabelle

You →Xavier · together at AFG - Association Française de la Gestion financière (2019–2022) →Isabelle

Ask Jamie Chen to introduce you to Isabelle

You →Jamie · 10 people · together at Seventure Partners →Isabelle

Ask Sam Okafor to introduce you to Isabelle

You →Sam · together at PFIZER France →Isabelle

Your email: the people you already email who know Isabelle
2nd- and 3rd-degree connections: people you know who worked, studied or invested with Isabelle
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

About

CEO and Managing Partner (Présidente du directoire) who leads Seventure's Life Sciences department, covering health, food, nutrition, digital health, microbiome, sport & wellness and blue economy. She joined Seventure in 2001 to build the Life Sciences division and founded the Health for Life Capital fund with Danone and Novartis, bringing over 25 years of international business development and finance experience in pharma and food.

Invests in

BiotechDigital HealthFoodTechHealthtechSports Tech

Experience

Seventure Partnersprésident du directoire / CEOcurrent2014 — presentGreater Paris Metropolitan Region
Seventure Partnerslifesciences department directorcurrent2001 — present
Seventure PartnersCEO / Directeur General2011 — 2014paris
AFG - Association Française de la Gestion financièrePrésident de la commission Capital Investissementcurrent2019 — presentGreater Paris Metropolitan Region
Gouvernement.frQualified personality for the French government "Conseil de l'innovation"2018 — 2021
NaturexBoard Member2015 — 2018Greater Avignon Area
COMIGEL sasIndependent board member2011 — 2018
Laboratoires FournierAssociate Director of Business Devlopment Departement1998 — 2001
PFIZER FranceBusiness Devpt Manager1993 — 1998
arthur andersen / EYAuditor1991 — 1993Detroit Metropolitan Area

Skills & more

Strategy99Management48Venture Capital99Private Equity39Corporate Development43Business Development50Lifesciences81Emerging Markets12Entrepreneurship39Life Sciences34Mergers9Due Diligence28

+12 more

Mergers & AcquisitionsBusiness StrategyStart-upsValuationBusiness PlanningInvestment BankingBiotechnologyTechnology TransferVenture FinancingLBOPharmaceutical IndustryBiopharmaceuticals

Languages English · French

From Isabelle's professional profile.

Investments

Board seats

Enterome BiosciencesFoodsmartMaat PharmaPolarisTargedysVedanta

Investor

Abalos TherapeuticsAnaeropharma ScienceArgenXBioallianceBiophytisCambrookeCitryllClinical MicrobiomicsCytoki PharmaDopavisionEnteromeErVimmuneExoFluxomeGraphite Innovation & TechnologiesInalveKariusLNC TherapeuticsMaaT PharmamachtfitMetabolic ExplorerMicrobiotica Myco TechnologyOPIPixium visionPOLARIS Push DoctorReboatSantarisSequentia BiotechSinayStarfish BioscienceString BioSyrocoVortex Io

Sources: the firm's website · curated public sources.

Leave your own feedback

Colleagues at Seventure Partners

Bruno Rivet

Senior Partner in the Digital Technologies/Sport at Seventure Partners

David Manjarres

Senior Partner - head of Digital Technologies team at Seventure Partners

Emmanuel Fiessinger

Senior Partner in the Lifesciences team at Seventure Partners

Manjarres David

Investor at Seventure Partners

Pierre Aumeunier

Chief Financial Officer at Seventure Partners

Frequently asked questions

Who is Isabelle de Cremoux?: CEO and Managing Partner (Présidente du directoire) who leads Seventure's Life Sciences department, covering health, food, nutrition, digital health, microbiome, sport & wellness and blue economy. She joined Seventure in 2001 to build the Life Sciences division and founded the Health for Life Capital fund with Danone and Novartis, bringing over 25 years of international business development and finance experience in pharma and food.
Where does Isabelle de Cremoux work?: Isabelle de Cremoux is CEO and Managing Partner at Seventure Partners.
What does Isabelle de Cremoux invest in?: Isabelle de Cremoux invests in Biotech, Digital Health, FoodTech, Healthtech, Sports Tech.
What check size does Isabelle de Cremoux write?: Isabelle de Cremoux typically writes checks of $685K – $27M.
What boards does Isabelle de Cremoux sit on?: Isabelle de Cremoux holds tracked board seats at Enterome Biosciences, Foodsmart, Maat Pharma, Polaris, Targedys, Vedanta.
What companies has Isabelle de Cremoux invested in?: Investments tracked here include Abalos Therapeutics, Anaeropharma Science, ArgenX, Bioalliance, Biophytis, Cambrooke, Citryll, Clinical Microbiomics, Cytoki Pharma, Dopavision, Enterome, ErVimmune, and 23 more.
Where did Isabelle de Cremoux go to school?: Isabelle de Cremoux studied at CentraleSupélec; DECF, ISEB.